<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; unfolded</title>
	<atom:link href="http://www.tapanray.in/tag/unfolded/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Getting unfolded a global opportunity for India with Biosimilar Drugs</title>
		<link>http://www.tapanray.in/getting-unfolded-a-global-opportunity-for-india-with-biosimilar-drugs/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=getting-unfolded-a-global-opportunity-for-india-with-biosimilar-drugs</link>
		<comments>http://www.tapanray.in/getting-unfolded-a-global-opportunity-for-india-with-biosimilar-drugs/#comments</comments>
		<pubDate>Mon, 19 Dec 2011 00:20:23 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[biologics]]></category>
		<category><![CDATA[biosimilar]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[for]]></category>
		<category><![CDATA[Getting]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[Guidelines]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[opportunity]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[unfolded]]></category>
		<category><![CDATA[with]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=159</guid>
		<description><![CDATA[Over a period of time, the trend of a disease treatment process is becoming more targeted and personalized to improve effectiveness of both diagnosis and treatment. Biotechnology being the key driver to this trend, India should not fall out of &#8230; <a href="http://www.tapanray.in/getting-unfolded-a-global-opportunity-for-india-with-biosimilar-drugs/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/getting-unfolded-a-global-opportunity-for-india-with-biosimilar-drugs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>China has recently unfolded the blueprints of its new healthcare reform measures, when will India do so?</title>
		<link>http://www.tapanray.in/china-has-recently-unfolded-the-blueprints-of-its-new-healthcare-reform-measures-when-will-india-do-so/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=china-has-recently-unfolded-the-blueprints-of-its-new-healthcare-reform-measures-when-will-india-do-so</link>
		<comments>http://www.tapanray.in/china-has-recently-unfolded-the-blueprints-of-its-new-healthcare-reform-measures-when-will-india-do-so/#comments</comments>
		<pubDate>Mon, 14 Sep 2009 01:30:36 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[blueprints]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[delivery]]></category>
		<category><![CDATA[do]]></category>
		<category><![CDATA[doctors]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[expenditure]]></category>
		<category><![CDATA[GDP]]></category>
		<category><![CDATA[has]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[hospitals]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[infrastructure]]></category>
		<category><![CDATA[its]]></category>
		<category><![CDATA[measures]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[nurses]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[oop]]></category>
		<category><![CDATA[out]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[pocket]]></category>
		<category><![CDATA[price]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[recently]]></category>
		<category><![CDATA[Reform]]></category>
		<category><![CDATA[so]]></category>
		<category><![CDATA[spend]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[unfolded]]></category>
		<category><![CDATA[when]]></category>
		<category><![CDATA[Will]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=780</guid>
		<description><![CDATA[Early April, 2009, China, a country with 1.3 billion people, unfolded a plan for a new healthcare reform process for the next decade to provide safe, effective, convenient and affordable healthcare services to all its citizens. A budgetary allocation of &#8230; <a href="http://www.tapanray.in/china-has-recently-unfolded-the-blueprints-of-its-new-healthcare-reform-measures-when-will-india-do-so/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/china-has-recently-unfolded-the-blueprints-of-its-new-healthcare-reform-measures-when-will-india-do-so/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
